Skip to main content
NVDA-2.39%AAPL+2.31%GOOGL+0.10%MSFT-0.02%AMZN+0.06%TSM-0.72%SPCX+1.69%AVGO-0.04%META+0.40%TSLA-0.45%SKHY-3.99%MU-4.17%BRK-B-0.06%LLY+0.40%JPM-0.38%AMD-2.33%WMT+0.16%V-0.25%XOM-0.26%ASMLa-1.56%JNJ-0.22%INTC-4.20%MA-0.59%0700.HK-1.94%ORCL-2.03%1398.HK+0.79%BAC-0.26%ABBV+0.52%CSCO-0.44%CVX-0.51%COST-0.10%LRCX-3.66%KO+0.59%CAT-0.99%AMAT-2.21%0005.HK-0.78%AP2d-1.57%UNH-0.63%DELL-2.88%HSBA.L-1.01%MS+0.01%PG-0.28%GE+0.11%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.34%HD-1.11%GS-0.18%0939.HK+1.66%NZDJPY-2.68%AUDJPY-1.96%CHFJPY-1.68%USDJPY-1.50%GBPJPY-1.39%EURJPY-1.37%CADJPY-1.36%EURNZD+1.36%NZDCAD-1.34%GBPNZD+1.31%NZDUSD-1.21%NZDCHF-1.04%USDNOK+0.91%EURNOK+0.87%CHFNOK+0.78%AUDNZD+0.75%USDZAR+0.68%USDSEK+0.68%NOKJPY-0.67%EURZAR+0.64%EURSEK+0.64%AUDDKK-0.63%AUDCAD-0.62%EURAUD+0.60%GBPAUD+0.55%GBPZAR+0.55%CHFSEK+0.54%AUDSGD-0.50%AUDUSD-0.46%USDTHB+0.45%USDMXN+0.42%GBPTRY+0.41%NZDSGD-0.32%GBPHKD+0.32%EURCHF+0.31%CADCHF+0.30%GBPMXN-0.28%AUDCHF-0.28%GBPCHF+0.27%USDPLN+0.25%AUDNOK+0.24%EURPLN+0.20%USDCHF+0.19%USDILS+0.16%USDSGD+0.16%EURUSD+0.13%USDCAD-0.12%EURSGD+0.12%GBPUSD+0.11%USDTRY+0.11%EURCZK-0.09%NZDMXN-0.08%SGDJPY+0.07%USDCNH+0.05%EURHKD-0.05%EURGBP+0.04%GBPCAD-0.04%USDCOP-0.04%EURCNH+0.04%USDDKK+0.03%GBPSGD+0.03%CHFSGD+0.03%USDHKD+0.01%PLNJPY-0.01%EURDKK-0.01%EURCAD0.00%XPTUSD-4.74%HG1-4.47%GAGUSD-4.15%XAGUSD-4.14%UKOIL+3.54%USOIL+3.11%SUGAR+1.50%XAUUSD-0.98%GAUUSD-0.98%COFFEE-0.76%COTTON+0.66%S1+0.65%BTCUSD-1.21%ETHUSD-1.02%USDTUSD-0.02%XRPUSD-2.60%SOLUSD-1.48%TRXUSDT0.00%ZECUSDT-5.54%DOGEUSD-2.81%XMRUSDT-1.66%LINKUSD-1.09%XLMUSD-1.92%BCHUSDT-10.38%LTCUSD-1.72%UNIUSD-3.29%TONUSD+24.88%HBARUSDT-1.85%SUIUSD-3.41%TAOUSDT-5.10%AAVEUSD-2.76%DOTUSDT-3.34%ICPUSDT-0.79%ONDOUSDT-2.76%WLDUSDT-2.43%ATOMUSDT-3.35%ARBUSDT+1.64%JUPUSDT-2.96%INJUSDT-4.80%STXUSDT-3.07%FETUSDT-3.57%TIAUSDT-0.87%PYTHUSDT+0.14%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-2.94%WIFUSDT-4.40%OPUSDT-3.00%IOTAUSDT-3.76%POLUSDT-5.71%AXSUSDT-2.47%FARTCOINUSDT-2.75%EOSUSDT-0.93%DYDXUSDT-0.80%ORDIUSDT-0.83%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.39%AAPL+2.31%GOOGL+0.10%MSFT-0.02%AMZN+0.06%TSM-0.72%SPCX+1.69%AVGO-0.04%META+0.40%TSLA-0.45%SKHY-3.99%MU-4.17%BRK-B-0.06%LLY+0.40%JPM-0.38%AMD-2.33%WMT+0.16%V-0.25%XOM-0.26%ASMLa-1.56%JNJ-0.22%INTC-4.20%MA-0.59%0700.HK-1.94%ORCL-2.03%1398.HK+0.79%BAC-0.26%ABBV+0.52%CSCO-0.44%CVX-0.51%COST-0.10%LRCX-3.66%KO+0.59%CAT-0.99%AMAT-2.21%0005.HK-0.78%AP2d-1.57%UNH-0.63%DELL-2.88%HSBA.L-1.01%MS+0.01%PG-0.28%GE+0.11%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.34%HD-1.11%GS-0.18%0939.HK+1.66%NZDJPY-2.68%AUDJPY-1.96%CHFJPY-1.68%USDJPY-1.50%GBPJPY-1.39%EURJPY-1.37%CADJPY-1.36%EURNZD+1.36%NZDCAD-1.34%GBPNZD+1.31%NZDUSD-1.21%NZDCHF-1.04%USDNOK+0.91%EURNOK+0.87%CHFNOK+0.78%AUDNZD+0.75%USDZAR+0.68%USDSEK+0.68%NOKJPY-0.67%EURZAR+0.64%EURSEK+0.64%AUDDKK-0.63%AUDCAD-0.62%EURAUD+0.60%GBPAUD+0.55%GBPZAR+0.55%CHFSEK+0.54%AUDSGD-0.50%AUDUSD-0.46%USDTHB+0.45%USDMXN+0.42%GBPTRY+0.41%NZDSGD-0.32%GBPHKD+0.32%EURCHF+0.31%CADCHF+0.30%GBPMXN-0.28%AUDCHF-0.28%GBPCHF+0.27%USDPLN+0.25%AUDNOK+0.24%EURPLN+0.20%USDCHF+0.19%USDILS+0.16%USDSGD+0.16%EURUSD+0.13%USDCAD-0.12%EURSGD+0.12%GBPUSD+0.11%USDTRY+0.11%EURCZK-0.09%NZDMXN-0.08%SGDJPY+0.07%USDCNH+0.05%EURHKD-0.05%EURGBP+0.04%GBPCAD-0.04%USDCOP-0.04%EURCNH+0.04%USDDKK+0.03%GBPSGD+0.03%CHFSGD+0.03%USDHKD+0.01%PLNJPY-0.01%EURDKK-0.01%EURCAD0.00%XPTUSD-4.74%HG1-4.47%GAGUSD-4.15%XAGUSD-4.14%UKOIL+3.54%USOIL+3.11%SUGAR+1.50%XAUUSD-0.98%GAUUSD-0.98%COFFEE-0.76%COTTON+0.66%S1+0.65%BTCUSD-1.21%ETHUSD-1.02%USDTUSD-0.02%XRPUSD-2.60%SOLUSD-1.48%TRXUSDT0.00%ZECUSDT-5.54%DOGEUSD-2.81%XMRUSDT-1.66%LINKUSD-1.09%XLMUSD-1.92%BCHUSDT-10.38%LTCUSD-1.72%UNIUSD-3.29%TONUSD+24.88%HBARUSDT-1.85%SUIUSD-3.41%TAOUSDT-5.10%AAVEUSD-2.76%DOTUSDT-3.34%ICPUSDT-0.79%ONDOUSDT-2.76%WLDUSDT-2.43%ATOMUSDT-3.35%ARBUSDT+1.64%JUPUSDT-2.96%INJUSDT-4.80%STXUSDT-3.07%FETUSDT-3.57%TIAUSDT-0.87%PYTHUSDT+0.14%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-2.94%WIFUSDT-4.40%OPUSDT-3.00%IOTAUSDT-3.76%POLUSDT-5.71%AXSUSDT-2.47%FARTCOINUSDT-2.75%EOSUSDT-0.93%DYDXUSDT-0.80%ORDIUSDT-0.83%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%
CT

Compass Therapeutics, Inc. (CMPX)

NASDAQ • Healthcare

$2.18
-$0.02 (-1.4%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$2.22
Previous Close$2.18
Day Range$2.17 - $2.25
Avg. Volume (3M)2.6M
Market Cap$392.5M
52 Week Range
$1.61$6.88
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$73.4M
EPS (TTM)
-$0.41
ROA (TTM)
-38.62%
Current Ratio
11.22

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+10.0%Q1 2026-$0.09
0.0%Q2 2026-$0.1
-17.5%Q3 2026-$0.13
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Compass Therapeutics, Inc.

Compass Therapeutics, Inc. is a NASDAQ-listed biotechnology company that develops antibody-based medicines for cancer. In qualitative terms it is a clinical-stage healthcare business centered on a small pipeline of immuno-oncology candidates, with CTX-009, CTX-471, and CTX-8371 forming the core of its research and development work.

Name
Compass Therapeutics, Inc.
CEO
Thomas J. Schuetz
Website
www.compasstherapeutics.com
Industry
Healthcare
Year Founded
2014
Employees
39

Today's Snapshot

AI-generated

CMPX opened 1.4% below yesterday's close, while its sector was flat.

Trading Volume

Below 10d avg (2.3M)

407.8K

vs S&P 500 Today

Underperforming Market

-2.10%

Updated: September 10, 2026 at 15:07 UTC

Technical Indicators

1 Buy2 Neutral5 Sell
CMPX is skewed toward selling pressure as large negative oscillator readings and persistent weakness versus moving averages dominate the picture. The CCI is deeply negative while shorter momentum measures are soft, and the stock trades beneath its short- and medium-term averages and well below the 200-day level, signaling broad technical deterioration. Trend strength is limited, volatility is notable relative to price, and OBV reflects net distribution. The pivot lies above the market, offering nearby resistance. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$2.29 - $3.51
    Sell
  • RSI (14)42.17
    Neutral
  • Stochastic %K (14, 3, 3)4.10
    Buy
  • MACD Level (12, 26)0.01
    Neutral

Peers & Related Assets

OMEROmeros Corporation
$19.39+1.4%
CRVSCorvus Pharmaceuticals, Inc.
$13.33-4.3%
FDMT4D Molecular Therapeutics, Inc.
$14.18-3.1%
FULCFulcrum Therapeutics, Inc.
$3.84+0.5%
GOSSGossamer Bio, Inc.
$0.16-11.2%
LXRXLexicon Pharmaceuticals, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.